醋酸地加瑞克

Name: 醋酸地加瑞克
Brand: 济南圣和化工有限公司

CAS 214766-78-6C82H103ClN18O16MW 1632.3

济南圣和化工有限公司现供应有机化学品——醋酸地加瑞克（CAS 214766-78-6），分子式 C82H103ClN18O16，分子量 1632.3。本页理化参数仅供参考，实际常规纯度按批次COA提供(不公开发布)，以批次 COA 及订单确认为准，支持批量采购与长期供货协议。

产品概览

CAS号	214766-78-6
分子式	C82H103ClN18O16
分子量	1632.3
LogP	3.5
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	有机化学品
类别	有机化学品

应用领域

有机化学品

醋酸地加瑞克在有机化学品领域使用广泛。采购前请确认纯度等级与包装形式，以批次 COA 为验收依据。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

供应说明：醋酸地加瑞克常规包装为按订单/批次确认(不公开发布)，储存时应密封置于阴凉干燥处，避免与氧化剂混放。济南圣和化工有限公司支持国内物流发货，大货交期与运费以订单确认为准。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

选择济南圣和化工有限公司的理由：产品信息透明（含 CAS、分子式、理化参数）、报价响应快（一个工作日内）、单证齐全（COA/MSS/质检资料按需提供）、支持批量与长期协议供货。如需醋酸地加瑞克以外的配套原料，也欢迎一并列出需求清单。

常见问题

醋酸地加瑞克的 CAS 号是多少？

醋酸地加瑞克的 CAS 号为 214766-78-6。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

醋酸地加瑞克有什么用途？

主要应用于有机化学品。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

Degarelix acetate · CAS 214766-78-6 · C82H103ClN18O16. UNII SX0XJI3A11.

Identification

CAS Registry Number	214766-78-6
PubChem CID	16136245
Molecular formula	C82H103ClN18O16
UNII (FDA)	SX0XJI3A11

Computed Descriptors

Molecular Weight	1632.3
XLogP3	3.5
Hydrogen Bond Donor Count	17
Hydrogen Bond Acceptor Count	18
Rotatable Bond Count	41
Exact Mass	1630.7487970
Monoisotopic Mass	1630.7487970
Topological Polar Surface Area	513
Heavy Atom Count	117
Formal Charge	0

Physical description & handling notes

White to off-white amorphous powder /Degarelix, acetate anhydrate/
Table: Degarelix Acetate Preparations [Table#7511]

GHS Hazard Classification

Reported hazard statements	H360 (100%)

H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]

P203, P280, P318, P405, and P501 (click each P-code to see the statement)

Documented Uses

Intended to treat patients with advanced prostate cancer ... slows the growth and progression of prostate cancer by suppressing testosterone
THERAPEUTIC CATEGORY: Antineoplastic (hormonal)
Gonadotropin-releasing hormone (GnRH) antagonist; decapeptide amide with seven unnatural amino acids, five of which are D-amino acids.
In Canada and the US, degarelix is indicated for the treatment of advanced prostate cancer in patients requiring androgen deprivation therapy. In the EU, it is more specifically indicated for the treatment of adult male patients with advanced hormone-dependent prostate cancer, and for treatment of high-risk localized and locally advanced hormone-dependent prostate cancer, in combination with radiotherapy or as a neo-adjuvant prior to radiotherapy.
Degarelix is a parenterally administered, gonadotropin releasing hormone (GnRH) antagonist that effectively blocks androgen production and is used to treat advanced prostate cancer. Degarelix therapy is associated with serum enzyme elevations during therapy, but has yet to be linked to instances of clinically apparent acute liver injury.
Degarelix is approved to treat:

Synonyms

Degarelix; 214766-78-6; SX0XJI3A11; FE-200486 (free base); DTXSID801026401; FE200486 ANHYDROUS FREE BASE; FE-200486 ANHYDROUS FREE BASE; degarelixum; RefChem:58687; L02BX02; DTXCID801510614; Firmagon; CHEMBL415606; FE200486; FE200486 (AS ACETATE SALT); Uglypeptide1

Frequently Asked Questions

What are the CAS number and molecular formula of Degarelix acetate?

CAS 214766-78-6; molecular formula C82H103ClN18O16; molecular weight — g/mol.

What other names is Degarelix acetate known by?

Degarelix, 214766-78-6, SX0XJI3A11, FE-200486 (free base), DTXSID801026401, FE200486 ANHYDROUS FREE BASE.

Is Degarelix acetate classified as hazardous?

Hazard statements reported: H360.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.